Estrogen signaling in the dorsal raphe regulates binge-like drinking in mice.

Estrogens promote binge alcohol drinking and contribute to sex differences in alcohol use disorder. However, the mechanisms are largely unknown. This study aims to test if estrogens act on 5-hydroxytryptamine neurons in the dorsal raphe nucleus (5-HTDRN) to promote binge drinking. We found that female mice drank more alcohol than male mice in chronic drinking in the dark (DID) tests. This sex difference was associated with distinct alterations in mRNA expression of estrogen receptor α (ERα) and 5-HT-related genes in the DRN, suggesting a potential role of estrogen/ERs/5-HT signaling. In supporting this view, 5-HTDRN neurons from naïve male mice had lower baseline firing activity but higher sensitivity to alcohol-induced excitation compared to 5-HTDRN neurons from naïve female mice. Notably, this higher sensitivity was blunted by 17ß-estradiol treatment in males, indicating an estrogen-dependent mechanism. We further showed that both ERα and ERß are expressed in 5-HTDRN neurons, whereas ERα agonist depolarizes and ERß agonist hyperpolarizes 5-HTDRN neurons. Notably, both treatments blocked the stimulatory effects of alcohol on 5-HTDRN neurons in males, even though they have antagonistic effects on the activity dynamics. These results suggest that ERs' inhibitory effects on ethanol-induced burst firing of 5-HTDRN neurons may contribute to higher levels of binge drinking in females. Consistently, chemogenetic activation of ERα- or ERß-expressing neurons in the DRN reduced binge alcohol drinking. These results support a model in which estrogens act on ERα/ß to prevent alcohol-induced activation of 5-HTDRN neurons, which in return leads to higher binge alcohol drinking.

An estrogen-sensitive hypothalamus-midbrain neural circuit controls thermogenesis and physical activity.

Estrogen receptor­α (ERα) expressed by neurons in the ventrolateral subdivision of the ventromedial hypothalamic nucleus (ERαvlVMH) regulates body weight in females, but the downstream neural circuits mediating this biology remain largely unknown. Here we identified a neural circuit mediating the metabolic effects of ERαvlVMH neurons. We found that selective activation of ERαvlVMH neurons stimulated brown adipose tissue (BAT) thermogenesis, physical activity, and core temperature and that ERαvlVMH neurons provide monosynaptic glutamatergic inputs to 5-hydroxytryptamine (5-HT) neurons in the dorsal raphe nucleus (DRN). Notably, the ERαvlVMH → DRN circuit responds to changes in ambient temperature and nutritional states. We further showed that 5-HTDRN neurons mediate the stimulatory effects of ERαvlVMH neurons on BAT thermogenesis and physical activity and that ERα expressed by DRN-projecting ERαvlVMH neurons is required for the maintenance of energy balance. Together, these findings support a model that ERαvlVMH neurons activate BAT thermogenesis and physical activity through stimulating 5-HTDRN neurons.

Bisphenol F Exposure in Adolescent Heterogeneous Stock Rats Affects Growth and Adiposity.

Bisphenol F (BPF) is increasingly substituting bisphenol A in manufacturing polycarbonates and consumer products. The cardiometabolic effects of BPF in either humans or model organisms are not clear, and no studies to date have investigated the role of genetic background on susceptibility to BPF-induced cardiometabolic traits. The primary goal of this project was to determine if BPF exposure influences growth and adiposity in male N:NIH heterogeneous stock (HS) rats, a genetically heterogeneous population. Littermate pairs of male HS rats were randomly exposed to either vehicle (0.1% ethanol) or 1.125 µg/ml BPF in 0.1% ethanol for 5 weeks in drinking water starting at 3 weeks-of-age. Water consumption and body weight was measured weekly, body composition was determined using nuclear magnetic resonance, urine and feces were collected in metabolic cages, and blood and tissues were collected at the end of the study. BPF-exposed rats showed significantly increased body growth and abdominal adiposity, risk factors for cardiometabolic disease. Urine output was increased in BPF-exposed rats, driving a trend in increased creatinine clearance. We also report the first relationship between a bisphenol metabolizing enzyme and a bisphenol-induced phenotype. Preliminary heritability estimates of significant phenotypes suggest that BPF exposure may alter trait variation. These findings support BPF exposure as a cardiometabolic disease risk factor and indicate that the HS rat will be a useful model for dissecting gene by BPF interactions on metabolic health.

Enfermedad de Rosai-Dorfman extranodal: presentación de un caso con afectación intracraneal aislada / Rosai-Dorfman Disease extranodal: report of a case with isolated intracranial involvement

La enfermedad de Rosai-Dorfman (ERD) es una enfermedad idiopática benigna caracterizada por una proliferación anormal de histiocitos. Desde que fue descripta por Rosai y Dorfman en 1969 son pocos los casos publicados en la literatura, aproximadamente 750 en el mundo. 1- 4La presentación clínica más frecuente son linfadenopatías cervicales bilaterales indoloras. La afectación extranodal ocurre en el 43% de los casos y el compromiso del sistema nervioso central en un 4%.1,3-8 Amos y cols. publican la existencia de 111 casos hasta el año 2008 con afectación del sistema nervioso central (SNC).9 Hasta el año 2011 se han publicado un total de 136 casos.En este artículo presentamos el caso de una paciente con ERD intracraneal sin afectación ganglionar, afectación excepcionalmente rara (únicamente se han publicado 24 casos).

Enfermedad de Rosai-Dorfman extranodal: presentación de un caso con afectación intracraneal aislada / Rosai-Dorfman Disease extranodal: report of a case with isolated intracranial involvement

La enfermedad de Rosai-Dorfman (ERD) es una enfermedad idiopática benigna caracterizada por una proliferación anormal de histiocitos. Desde que fue descripta por Rosai y Dorfman en 1969 son pocos los casos publicados en la literatura, aproximadamente 750 en el mundo. 1- 4La presentación clínica más frecuente son linfadenopatías cervicales bilaterales indoloras. La afectación extranodal ocurre en el 43% de los casos y el compromiso del sistema nervioso central en un 4%.1,3-8 Amos y cols. publican la existencia de 111 casos hasta el año 2008 con afectación del sistema nervioso central (SNC).9 Hasta el año 2011 se han publicado un total de 136 casos.En este artículo presentamos el caso de una paciente con ERD intracraneal sin afectación ganglionar, afectación excepcionalmente rara (únicamente se han publicado 24 casos).(AU)